相关产品推荐更多 >

EZElisa™人PIGF-1酶联免疫试剂盒-EZElisa™ Human PIGF-1 ELISA Kit
询价
EZElisa ™ 4—hydroxynonial(4—HNE)ELISA试剂盒(ELISA试剂盒)-EZElisa™ 4-Hydroxynonenal (4-HNE) ELISA Kit
询价
EZElisa™ IV型牛胶原蛋白(COL4)ELISA试剂盒-EZElisa™ Bovine Collagen Type IV (COL4) ELISA Kit
询价
EZElisa™人角质细胞生长因子(KGF)ELISA试剂盒-EZElisa™ Human Keratinocyte Growth Factor (KGF) ELISA Kit
询价
EZElisa™胆囊收缩素B受体(CCKBR)试剂盒-EZElisa™ Cholecystokinin B Receptor (CCKBR) Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
运输过程中保存:2-8℃
- 保质期:
1年
- 英文名:
EZElisa™ Human Natural CytoToxicity triggering Receptor 1 (NCR1) ELISA Kit
- 库存:
100
- 供应商:
艾美捷科技
EZElisa™人天然细胞毒性触发受体1(NCR 1)ELISA试剂盒,EZElisa™ Human Natural CytoToxicity triggering Receptor 1 (NCR1) ELISA Kit,天然细胞毒性触发受体1(NCR 1)ELISA试剂盒, Natural CytoToxicity triggering Receptor 1 (NCR1) ELISA Kit
产品名称:EZElisa™人核仁素(NCL)ELISA试剂盒-EZElisa™ Human Natural CytoToxicity triggering Receptor 1 (NCR1) ELISA Kit
产品货号:A-QEK05259-96wells
产品规格:96wells

Enzyme Immunoassay for the estimation of Natural CytoToxicity triggering Receptor 1 (NCR1) in serum and plasma, tissue homogenates and other biological fluids.
种属:Human
检测方法:比色法
检测范围:

该EZElisa™人天然细胞毒性触发受体1(NCR 1)ELISA试剂盒ELISA的特点包括:即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证,符合金环标准质量ELISA的要求,这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物,样品可以是血清

运输过程中保存:2-8℃
点击:EZElisa™人核仁素(NCL)ELISA试剂盒-EZElisa™ Human Natural CytoToxicity triggering Receptor 1 (NCR1) ELISA Kit更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Crosslinking of molecules involved in the recognition of target cells elicits natural killer (NK) cell cytotoxicity, inducing either release of preformed cytotoxic mediators via granule exocytosis, or (enhanced) expression of ligands for target
Isolation and Analysis of Human Natural Killer Cell Subsets
Natural killer (NK) cells were originally defined as mediators of spontaneous cytotoxicity against virus-infected and tumor cells. In human peripheral blood, the majority of NK cells can mediate cell lysis mainly through perforin
Natural Killer Cell Reprogramming with Chimeric Immune Receptors
Natural killer (NK) cells are emerging as a new tool for cell therapy of cancer. However, some cancer subtypes are relatively resistant to NK cell cytotoxicity. Expression of anti-CD19 chimeric signaling receptors can enhance NK-cell
技术资料暂无技术资料 索取技术资料




